Публикации в чуждестранни списания

  1. Milanov, I. Mechanisms of electroacupuncture action on spasticity. American Journal of Acupuncture, 1991, 19, 2, 107-115.
  2. Milanov, I. Mechanisms of Baclofen action on spasticity. Acta Neurologica Scandinavica, 1992, 85, 5, 305-310.
  3. Milanov, I. Mechanisms of Tetrazepam action on spasticity. Acta Neurologica Belgica, 1992, 92, 5-15.
  4. Milanov, I. A comparison of methods to assess the excitability of lower motoneurones. The Canadian Journal of Neurological Sciences, 1992, 19, 1, 64-68.
  5. Milanov, I. F-wave for assessment of segmental motoneurone excitability. Electromyography and clinical Neurophysiology, 1992, 32, 1-2, 11-15.
  6. Milanov, I. Flexor reflex for assessment of common interneurone activity in spasticity. Electromyography and clinical Neurophysiology, 1992, 32, 12, 621-629.
  7. Milanov, I. A comparative study of methods for estimation of presynaptic inhibition. Journal of Neurology, 1992, 239, 287-292.
  8. Milanov, I. Electroacupuncture treatment of lumbosacral disc root disease. Akupuntur, 1993, 21, 3, 183-189.
  9. Milanov, I., Toteva, S. Acupuncture treatment of tremor in alcohol withdrawal syndrome. American Journal of Acupuncture, 1993, 21, 4, 319-322.
  10. Milanov, I., Georgiev, D. Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome. The Canadian Journal of Neurological Sciences, 1994, 21, 1, 60-63.
  11. Milanov, I. Examination of the segmental pathophysiological mechanisms of spasticity. Electromyography and clinical Neurophysiology, 1994, 34, 2, 73-79.
  12. Milanov, I., Georgiev, D. Mechanisms of Tizanidine action on spasticity. Acta Neurologica Scandinavica, 1994, 89, 274-279.
  13. Milanov, I., Georgiev, D. Writer's cramp and tremor due to brain tumor. The Canadian Journal of Neurological Sciences, 1995, 22, 59-61.
  14. Kolev, O.I, Milanov, I. Vestibular and auditory influences on segmental motoneuron excitability-a comparative study. Neuroscience Letters, 1995, 184, 193-196.
  15. Milanov, I. Neurographic studies in hemiplegic patients. Functional Neurology, 1995, 10, 2, 77-82.
  16. Milanov, I., Georgiev, D. Spasmodic torticollis and tremor due to multiple sclerosis. Functional Neurology, 1995, 10, 6, 281-285.
  17. Milanov, I., Toteva, S., Georgiev, D. Alcohol withdrawal tremor. Electromyography and clinical Neurophysiology, 1996, 36, 1, 15-20.
  18. Toteva, S.,  Milanov, I. The use of body acupuncture for treatment of alcohol dependence and withdrawal syndrome: A controlled study. American Journal of Acupuncture, 1996, 24, 1, 19-25.
  19. Milanov, I., Georgiev, D., Krushkov, Ch. Scapuloperoneal muscular atrophy: Davidenkow's syndrome. Electromyography and clinical Neurophysiology, 1996, 36, 5, 259-263.
  20. Ishpekova, B., Milanov, I. Differential diagnosis of limb-girdle syndromes. Electromyography and clinical Neurophysiology, 1996, 36, 8, 469-475.
  21. Milanov, I., Ishpekova, B. Differential diagnosis of scapuloperoneal syndrome. Electromyography and clinical Neurophysiology, 1997, 37, 2, 73-78.
  22. Ishpekova, B., Milanov, I. Distal muscular dystrophy. Electromyography and clinical Neurophysiology, 1997, 37, 4, 201-205.
  23. Milanov, I. Can clinical neurophysiology help on the tension-type headache? EHF News, 1997, 9, 1-3.
  24. Milanov, I., Georgiev, D., Kmetska, K., Jordanova, L., Topalov, N.  Prevalence of Multiple Sclerosis in Bulgaria. Neuroepidemiology, 1997, 16, 6, 304-307.
  25. Bogdanova, D., Milanov, I., Georgiev, D. Parkinsonian syndrome as a neurological manifestation of Behcet's disease. A case report. The Canadian Journal of Neurological Sciences, 1998, 25, 82-85.
  26. Milanov, I., Ishpekova, B. Differential diagnosis of chronic idiopathic polymyositis and neuromyositis. Electromyography and clinical Neurophysiology, 1998, 38, 3, 183-187.
  27. Milanov, I., Rashkov, R., Baleva, M., Georgiev, D. Antiphospholipid syndrome and parkinsonism. Clinical and Experimental Rheumatology, 1998, 16, 5, 623-624.
  28. Milanov, Iv., Bogdanova, D., Georgiev, D. Contralateral hemi-parkinsonism and atypical tremor after stroke (a case report). Parkinsonism and Related Disorders, 1998, 4, 143-145.
  29. Sandrini, G., Milanov, I., Willer, J.C., Alfonsi, E., Moglia, A., Nappi, G. Different effect of high doses of naloxone on spinal reflexes in normal subjects and chronic paraplegic patients. Neuroscience Letters, 1999, 261, 5-8.
  30. Milanov, I., Topalov, N., Kmetski, Ts. Prevalence of Multiple Sclerosis in Gypsies and Bulgarians. Neuroepidemiology, 1999, 18, 4, 218-222.
  31. Sandrini, G., Proietti Cecchini, A., Pucci E., Milanov, I., Nappi, G. Neurophysiological approach to the study of cluster headache. The Italian Journal of Neurological Sciences, 1999, 20, Suppl. 2, 31-33.
  32. Ishpekova, B., Milanov, I., Christova, L.G., Alexandrov, A.S. Comparative study between Duchenne and Becker types muscular dystrophy. Electromyography and clinical Neurophysiology, 1999, 39, 315-318.
  33. Kolev, O.I., Milanov, I. Central nervous system impairment in diabetic patients. Electromyography and clinical Neurophysiology, 1999, 39, 8, 479-484.
  34. Milanov, I. Clinical and neurophysiological correlations of spasticity. Functional Neurology, 1999, 14, 4, 193- 201.
  35. Milanov, I., Georgiev, D., Todorov, T. Clinical and electromyographic characteristics of tremor in patients with depression. Parkinsonism and Related Disorders, 2000, 6, 2, 101 - 105.
  36. Milanov, I. Clinical and electromyographic examinations of patients with essential tremor. The Canadian Journal of Neurological Sciences, 2000, 27, 1, 65-70.
  37. Ishpekova, B., Milanov, I. Differential diagnosis of amyotrophic lateral sclerosis and similar syndromes. Electromyography and clinical Neurophysiology, 2000, 40, 145-149.
  38. Milanov, I., Kmetski, Ts., Lyons, K.E., Koller, W.C. Prevalence of Parkinson’s disease in Bulgarian Gypsies. Neuroepidemiology, 2000, 19, 4, 206-209.
  39. Milanov, I., Sheinkova, G. Clinical and electromyographic examinations of tremor in patients with thyrotoxicosis. International Journal of Clinical Practice, 2000, 54, 6, 364-367.
  40. Sandrini, G., Milanov, I., Malaguti, S., Nigrelli, M.P., Moglia, A., Nappi, G. Effects of hypnosis on diffuse noxious inhibitory controls. Physiology & Behavior, 2000, 69, 295-300.
  41. Milanov, I. Clinical and electromyographic examinations of parkinsonian tremor. Parkinsonism and Related Disorders, 2000, 6, 229-235.
  42. Milanov, I.G. Evaluation of presynaptic inhibition by comparing the amplitudes of H reflexes and F waves. Is it possible? Electromyography and clinical Neurophysiology, 2000, 40, 8, 491-495.
  43. Sandrini, G., Antonaci, F., Lanfranchi, S., Milanov, I., Danilov, A., Nappi, G. Asymmetrical reduction of the nociceptive flexion reflex threshold in cluster headache. Cephalalgia, 2000, 20, 647-652.
  44. Sandrini, G., Milanov, I., Rossi, B., Murri, L., Alfonsi, E., Moglia, A., Nappi, G. Effects of sleep on spinal nociceptive reflexes in humans. Sleep, 2001, 24, 1, 13 - 17.
  45. Milanov, I., Bogdanova, D. Antiphospholipid syndrome and dystonia - parkinsonism. A case report. Parkinsonism and Related Disorders, 2001, 7, 139-141.
  46. Ishpekova, B., Milanov, I. Differential diagnosis of myasthenic syndromes. Electromyography and clinical Neurophysiology, 2001, 41, 17-21.
  47. Milanov, I., Kolev, P. Clinical and electromyographic examinations of patients with tremor after chronic occupational lead exposure. Occupational Medicine, 2001, 51, 3, 157-162.
  48. Milanov, I., Bogdanova, D., Ishpekova, B. The trigemino-cervical reflex in normal subjects. Functional Neurology, 2001, 16, 2, 129-134.
  49. Milanov, I., Kmetska, K., Karakolev, B., Nedialkov, E. Prevalence of Parkinson’s disease in Bulgaria. Neuroepidemiology, 2001, 20, 3, 212-214.
  50. Milanov, I. Electromyographic differentiation of tremors. Clinical Neurophysiology, 2001, 112, 1626 -1632.
  51. Milanov, I. A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor. Parkinsonism and Related Disorders, 2001, 8, 67 - 73.
  52. Milanov, I. Motoneuron activity in patients with different types of tremor. Electromyography and clinical Neurophysiology, 2001, 41, 8, 479 - 484.
  53. Milanov, I. Clinical and electromyographic assessment of essential tremor treatment. Parkinsonism and Related Disorders, 2002, 8, 5, 343-348.
  54. Sandrini, G., Proietti-Cecchini, A., Milanov, I., Tassorelli, C., Buzzi, M.G., Nappi, G. Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neuroscience Letters, 2002, 317, 135-138.
  55. Milanov, I. Clinical and electromyographic examinations of patients with midbrain and cerebellar tremor. Electromyography and clinical Neurophysiology, 2002, 42, 2, 105 - 112.
  56. Milanov, I. Correlation between tremor parameters. Functional Neurology, 2002, 17, 1, 19 - 23.
  57. Milanov, I. Clinical and electromyographic examinations of patients with psychogenic tremor. Electromyography and clinical Neurophysiology, 2002, 42, 7, 387 - 392.
  58. Milanov, I., Bogdanova, D. Trigemino-cervical reflex in patients with headache. Cephalalgia, 2003, 23, 1, 35 - 38.
  59. Tzvetanov, Pl., Rousseff, R.T., Milanov, I. Lower limb SSEP changes in stroke - predictive values regarding functional recovery. Clinical Neurology and Neurosurgery, 2003, 105, 121-127.
  60. Tzvetanov, Pl., Milanov, I., Rousseff, R.T., Christova, P. Can SSEP results predict functional recovery of stroke patients within the “Therapeutic Window”? Electromyography and clinical Neurophysiology, 2004, 44, 43 - 49.
  61. Milanov, I., Bogdanova, D.  Pain and tension-type headache: a review of the possible pathophysiological mechanisms.  The Journal of Headache and Pain, 2004, 5, 1, 4-11.
  62. Dimova, P.S., Bojinova, V., Georgiev, D., Milanov, I. Acute reversible Parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness. Movement Disorders, 2006, 21, 4, 564-566.
  63. Sandrini, G., Rossi, P., Milanov, I., Serrao, M., Cecchini, A.P., Nappi, G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia, 2006, 26, 782-789.
  64. Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Vecsei, L., Milanov I. The epidemiology of multiple sclerosis in Europe. European Journal of Neurology, 2006, 13, 700 - 722.
  65. Philipova, D., Georgiev, S., Milanov, I., Bogdanova, D., Wolf, W. Response slowing of parkinsonian patients under auditory discrimination tasks. Homeostasis, 2006, 44, 3, 109-118.
  66. Milanov, I. Clinical and electromyographic characteristics of tremor in patients with generalized anxiety disorder. Electromyography and clinical Neurophysiology, 2007, 47, 1, 3 - 9.
  67. Benkova, B., Lozanov, V., Ivanov, I.P., Todorova, A., Milanov, I., Mitev, V. Determination of plasma aminothiols by high performance liquid chromatography after precolumn derivatization with N-(2-acridonyl)maleimide. Journal of Chromatography B. 2008, 870, 1, 103 -108.
  68. Winblad, B., Fioravanti, M., Dolezal, T., Logina, I., Milanov, I.G., Popescu, D.C., Solomon, A. Therapeutic use of nicergoline. Clinical Drug Investigation, 2008, 28, 9, 533 - 552. 
  69. Todorova, A., Milanov, I., Maslarov, D. Investigating quality of life in Bulgarian patients with Parkinson’s disease. International Journal of Neuroprotection and Neurodegeneration, 2008, 4, 2, 151 – 157.
  70. Garren, H., Robinson, W.H., Krasulova, E., Havrdova, E., Nadj, C., Selmaj, K., Losy, J., Nadj, I., Radue, E.W., Kidd, B.A., Gianettoni, J., Tersini, K., Utz, P.J., Valone, F., Steinman, L., Milanov, I., Georgiev, D., Shotekov, P., Stamenova, P., Vojinovic, S., Kanovsky, P., Dolezil, D., Ehler, E., Keller, O., Stourac, P., Erälinna, J.P., Koivisto, K., Valpas, J., Golovchenko, Y., Sokolova, L., Grinchuk, A., Moskovko, S., Kwiecinski, H., Wajgt, A., Tutaj, A., Podemski, R., Nica, S., Balasa, R., Simu, M.A., Stolyarov, I., Odinak, M., Skoromets, A., Gusev, E., Zavalishin, I., Belova, A.N., Zaslavskiy, L., Turcani, P., Prochazkova, L., Vyletelka, J., Kurca, E., Szilasiova, J., Hawkes, C., Sharrack, B., Kasper L. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Annals of Neurology, 2008, 63, 5, 611-620.
  71. Dimova, P.S., Bojinova, V.S., Milanov, I.G. Transient mutism and pathologic laughter in the course of cerebellitis. Pediatric Neurology, 2009, 41, 49-52.
  72. Hauser, R.A., Bronzova, J., Sampaio, C., Lang, A.E., Rascol, O., Theeuwes, A., Van de Witte, S.V., Milanov, I., Shotekov, P., Haralanov, L., Petrov, I., Stamenova, P., Hristova, D., Kostic, V., Vojinvic, S., Raicevic, R. Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized controlled study of patients with advanced Parkinson’s disease. European Neurology, 2009, 62, 40-48.
  73. Bousser, M.G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M.G., Mattle, H.P., Rothwell, P.M., PERFORM Study Investigators. Rationale and design of a randomized, double-blind, parallel-group study of Terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: The prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular Diseases, 2009, 27, 5, 509-518.
  74. Bousser, M.G. Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M., Mattle, H.P., Rothwell, P.M., PERFORM Study Investigators. The prevention of cerebrovascular and cardiovascular events of ischemic origin with Terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) Study: Baseline characteristics of the population. Cerebrovascular Diseases, 2009, 27, 6, 608-613.
  75. Bronzova, J., Sampaio, C., Hauser, R.A., Lang, A.E., Rascol, O., Theeuwes, A., Van de Witte, S.V., Van Scharrenburg, G., Milanov, I., Shotekov, P., Polivka, J., Dolezil, D., Jolma, T., Soininen, H., on behalf of the Bruegel Study Group. Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson’s disease. Movement Disorders, 2010, 25, 6, 738-746.
  76. Giovannoni, G., Comi, G., Cook, S., Rammohan, K., Rieckmann, P., Sorensen, P.S., Vermersch, P., Chang, P., Hamlett, A., Musch, B., Greenberg, S.J., CLARITY Study Group. Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis. New England Journal of Medicine, 2010, 362, 5, 416-426.
  77. De Stefano, N., Curtin, F., Stubinski, B., Blevins, G., Drulovic, J., Issard, D., Shotekov, P., Gasperini, C., IMPROVE Study Investigators. Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 2010, 16, 7, 888-892.
  78. Bousser, M.G., Amarenco, P., Chamorro, A., Ford, I., Fox, K.M., Hennerici, M.G.,  Mattle, H.P., Rothwell, P.M., de Cordoue, A., Fratacci, M.D., PERFORM Study Investigators. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial. Lancet, 2011, 377, 9782, 2013-2022.
  79. Klissurski, M., Milanov, I., Stamenova, P., Troyanova, P., Vassileva, E., Dulgerova, P. Mesencephalic form of meningoencephalitis in a patient with HLA-B51 Behcet’s disease: case report. Acta Clin. Croat., 2011, 50, 435-441.  
  80. Jensen, R., Tassorelli, C., Rossi, P., Allena, M., Osipova, V., Steiner, T.J., Sandrini, G., Olesen, J., Nappi, G., Barrientos, N., Mulleners, W.M., Dzagnidze, A., Figuerola, M.L., Filatova, E.G., Katsarava, Z., Koreshkina, M., Milanov, I., Pereira-Monteiro, J., Perrotta, A., Ratchin, A., Radojicic, A., Rezzani, C., Sances, G., Sretenovic, S., Torelli, P. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. A multicenter European and Latin American study. Cephalalgia, 2011, 31, 15, 1549-1560.
  81. De Stefano, N., Sormani, M.P., Stubinski, B., Blevins, G., Drulovic, J.S., Issard, D., Shotekov, P., Gasperini, C. Efficacy and safety of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: Further outcomes from the IMPROVE study. Journal of the Neurological Sciences, 2012, 312, 1-2, 97-101.  
  82. Dimitrov, I., Tzourio, C., Milanov, I., Deleva, N., Traykov, L. Prevalence of Dementia and Mild Cognitive Impairment in a Bulgarian Urban Population. American Journal of Alzheimer’s Disease & Other Dementias, 2012, 27, 2, 131-135.
  83. Pacheva, I., Milanov, I., Ivanov, I., Stefanov, R. Evaluation of diagnostic and prognostic value of clinical characteristics of Migraine and Tension type headache included in the diagnostic criteria for children and adolescents in the international Classification of Headache disorders – second edition. The International Journal of Clinical Practice, 2012, 66, 12, 1168-1177.
  84. Fazekas, F., Berger, T., Kraus, J., Vass, K., Milanov, I., Traykov, L., Kyriakides, T., Panayiotou, P., Havrdova, E., Talab, R., Jakab, G., Komoly, S., Vella, N., Kurca, E., Lisy, L., Turcani, P., Hojs, F.T., Horvat, L.A., Sega, J.S. Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS expert group. Wien Medizinische Wochenschrift, 2012, 162, 354-366.
  85. Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M.A., Filippi, M., ALLEGRO Study Group. Placebo-controlled trial of oral laquinimod for multiple sclerosis. New England Journal of Medicine, 2012, 366, 11, 1000-1009.
  86. Fazekas, F., Bajenaru, O., Berger, T., Fabjan, T.H. Ledinek, A.H., Jakab, G., Komoly, S., Kobys, T., Kraus, J., Kurca, E., Kyriakides, T., Lisý, L., Milanov, I., Nehrych, T., Moskovko, S., Panayiotou,
 P., Jazbec, S.Š., Sokolova, L., Taláb, R., Traykov, L., Turcáni, P., Vass, K., Vella, N., Voloshyná, N., Havrdová, E. How does fingolimod (Gilenya®) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis? Frontiers in Neurology, 2013, 4, 10, 1-14.
  87. Milenkova, M., Milanov, I., Kmetska, K., Deleva, S., Popova, L., Hadjidekova, V., Groudeva, V., Hadjidekova, S., Dominguez, I. Chromosomal radiosensitivity in patients with multiple sclerosis. Mutation Research, 2013, 28, 749, (1-2), 3-8.
  88. Boeru, G., Milanov, I., De Robertis, F., Kozubski, W., Lang, M., Rojas-Farreras, S., Tomlinson, M. ExtaviJect® 30g device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Medical Devices: Evidence and Research, 2013, 6, 175-184.
  89. Filippi, M., Rocca, M.A., Pagani, E., De Stefano, N., Jeffery, D., Kappos, L., Montalban, X., Boyko, A.N., Comi, G. on behalf of the ALLEGRO Study Group. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. J. Neurology, Neurosurgery, Psychiatry, 2014, 85, 8, 851-858.
  90. Calabresi, P.A., Kieseier, B.C., Arnold, D.L., Balcer, L.J., Boyko, A., Pelletier, J., Liu, S., Zhu, Y., Seddighzadeh, A., Hung, S., Deykin, A., for the ADVANCE Study Investigators. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. The Lancet Neurology, 2014, 13, 7, 657-665.
  91. Semerdjieva, N., Milanov, I. Frequency of primary torsion dystonia for the population of Bulgaria – A service based survey. Journal of Neurology and Epidemiology, 2014, 2, 1, 38-41.
  92. Barkhof, F., Hulst, H.E., Drulovic, J., Uitdehaag, B.MJ., Matsuda, K., Landin, R., Shotekov, P.M., Haralanov, L., Milanov, I., Titianova, E., Ponomarev, V., Nadj, C., Vojinovic, S., Dincic, E., Toncev, G., Potic, J., Loganovsky, K., Nechrych, T., Moskovko, S., Sokolova, L., Voloshyna, N. Ibudilast in relapsing-remitting multiple sclerosis. Neurology, 2010, 74, 13, 1033-1040.
  93. Goetz, C.G., Damier, P., Hicking, C., Laska, E., Muller, T., Olanow, C.W., Rascol, O., Russ, H., Bajaj, N., Barker, R., Blin, O., Burn, D., Carciumaru, N., Ceballos-Baumann, A., Constantin, D., Csanyi, A., Cunha, L., Damier, P., Dom, R., Durif, F., Fernandez, H., Ferreira, J.J., Fine, J., Gacs, G., Giampaolo, D.L., Grunewald, R., Harcos, P., Horn, S., Jankovic, J., Jost, W.H., Koller, W.C., Lurie, D.M., Martin, W.R.W., Milanov, I.G., Moser, A., Muller, T., Pahwa, R., Pascu, I., Pfeiffer, R., Rascol, O., Reichmann H., Sagi, I., Sahay, A., Saint-Hillaire, M., Schwarz, J., Serbanescu, A., Sethi, K.D., Shotekov, P.M., Singer, C., Smuts, J., Stamenova, P., Storch, A., Tetrud, J.W., Thorne, J., Truong, D.D., Tsui, J., Veleva, S.I., Verhagen, L., Watts, R.L., Woitalla, D., Zesiewicz, T. Sarizotan as a treatment for dyskinesias in Parkinson’s disease: A double-blind placebo-controlled trial. Movement Disorders, 2007, 22, 2, 179–186.
  94. Dib, M., Zahra, I.K.A., Chankrachang, S., Czlonkowska, A., Fedin, A.I., Manvelyan, H., Mendez, A., Milanov, I., Ogun, Y., Pakdaman, H., Tugasworo, D. NeuroAiDTM (MLC601, MLC901): A new bench-to-bedside approach to the treatment of ischemic brain injury. European Journal of Medicinal Plants, 2015, 5, 2, 117-126.
  95. Panov, G., Milanov, I., Pacheva, I. Prevalence and characteristics of psychotic episodes in patients with resistant and well-controlled epileptic seizures. Platinum Global Journal of Medicine and Medical Sciences, 2015, 1, 2, 7-13.
  96. Popivanova, B.A., Milanov, I.G., Kmetska, K.H., Kalvatchev, Z., Grozeva, V. Serum levels of EBVNA-IgG and EBVCA-IgG in patients with multiple sclerosis. Balkan Military Medical Review, 2015, 1-4.